Rapid clearance of circulating tumor DNA during treatment with AZD9291 of a lung cancer patient presenting the resistance EGFR T790M mutation

Lung Cancer ◽  
2016 ◽  
Vol 91 ◽  
pp. 73-74 ◽  
Author(s):  
Audrey Vallée ◽  
Clarisse Audigier-Valette ◽  
Guillaume Herbreteau ◽  
Julien Merrien ◽  
Laurent Tessonnier ◽  
...  
2019 ◽  
Vol 71 ◽  
pp. 49-51
Author(s):  
Dinesh Chandra Doval ◽  
Rupal Tripathi ◽  
Kumardeep Dutta Choudhury ◽  
Ajay Sharma ◽  
Ullas Batra ◽  
...  

Lung cancer treatment based on the molecular classifi cation of the tumor has paved the way for multiple lines of targeted treatment, even though the development of resistance remains a major cause of concern. Epidermal growth factor receptor (EGFR) remains the poster boy for the use of targeted therapy, and the presence/absence of mutations in this gene has led to the development of inhibitors targeting specifi c mutations. We present the case of an advanced non-small cell lung cancer patient with EGFR T790M mutation treated with Osimertinib, a third-generation inhibitor.


2017 ◽  
Vol 22 ◽  
pp. 31-33 ◽  
Author(s):  
Yuki Iijima ◽  
Yosuke Hirotsu ◽  
Kenji Amemiya ◽  
Seishi Higashi ◽  
Yoshihiro Miyashita ◽  
...  

2018 ◽  
Vol Volume 10 ◽  
pp. 1209-1218 ◽  
Author(s):  
Rui Zhang ◽  
Bojiang Chen ◽  
Xiang Tong ◽  
Ye Wang ◽  
Chengdi Wang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document